Literature DB >> 18198270

A meta-analytic review of psychosocial interventions for substance use disorders.

Lissa Dutra1, Georgia Stathopoulou, Shawnee L Basden, Teresa M Leyro, Mark B Powers, Michael W Otto.   

Abstract

OBJECTIVE: Despite significant advances in psychosocial treatments for substance use disorders, the relative success of these approaches has not been well documented. In this meta-analysis, the authors provide effect sizes for various types of psychosocial treatments, as well as abstinence and treatment-retention rates for cannabis, cocaine, opiate, and polysubstance abuse and dependence treatment trials.
METHOD: With a comprehensive series of literature searches, the authors identified a total of 34 well-controlled treatment conditions-five for cannabis, nine for cocaine, seven for opiate, and 13 for polysubstance users-representing the treatment of 2,340 patients. Psychosocial treatments evaluated included contingency management, relapse prevention, general cognitive behavior therapy, and treatments combining cognitive behavior therapy and contingency management.
RESULTS: Overall, controlled trial data suggest that psychosocial treatments provide benefits reflecting a moderate effect size according to Cohen's standards. These interventions were most efficacious for cannabis use and least efficacious for polysubstance use. The strongest effect was found for contingency management interventions. Approximately one-third of participants across all psychosocial treatments dropped out before treatment completion compared to 44.6% for the control conditions.
CONCLUSIONS: Effect sizes for psychosocial treatments for illicit drugs ranged from the low-moderate to high-moderate range, depending on the substance disorder and treatment under study. Given the long-term social, emotional, and cognitive impairments associated with substance use disorders, these effect sizes are noteworthy and comparable to those for other efficacious treatments in psychiatry.

Entities:  

Mesh:

Year:  2008        PMID: 18198270     DOI: 10.1176/appi.ajp.2007.06111851

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  400 in total

1.  Onset, Comorbidity, and Predictors of Nicotine, Alcohol, and Marijuana Use Disorders Among North American Indigenous Adolescents.

Authors:  Dane Hautala; Kelley Sittner; Melissa Walls
Journal:  J Abnorm Child Psychol       Date:  2019-06

2.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

3.  Rationale for Using Exercise in the Treatment of Stimulant Use Disorders.

Authors:  Tracy L Greer; Kolette M Ring; Diane Warden; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes; Madhukar H Trivedi
Journal:  J Glob Drug Policy Pract       Date:  2012

4.  Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  J Dual Diagn       Date:  2014

5.  Financial incentives for abstinence among socioeconomically disadvantaged individuals in smoking cessation treatment.

Authors:  Darla E Kendzor; Michael S Businelle; Insiya B Poonawalla; Erica L Cuate; Anshula Kesh; Debra M Rios; Ping Ma; David S Balis
Journal:  Am J Public Health       Date:  2014-11-13       Impact factor: 9.308

6.  A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence.

Authors:  Michael W Otto; Bridget A Hearon; R Kathryn McHugh; Amanda W Calkins; Elizabeth Pratt; Heather W Murray; Steven A Safren; Mark H Pollack
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

7.  Compensation effects on clinical trial data collection in opioid-dependent young adults.

Authors:  Claire E Wilcox; Michael P Bogenschutz; Masato Nakazawa; George E Woody
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09-22       Impact factor: 3.829

Review 8.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

Review 9.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 10.  Event-Related Potentials as Biomarkers of Behavior Change Mechanisms in Substance Use Disorder Treatment.

Authors:  Rebecca J Houston; Nicolas J Schlienz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.